The Patent Finder
US

Nonsteroidal immunomodulating kit and composition and uses thereof

US 9,668,972 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Jun 6, 2025 on the fee record · Low confidence

Second maintenance fee unpaid; grace period ended.

Filed Mar 11, 2005 as application 11/078,902 · Granted Jun 6, 2017
Base term, 20 years from filing, plus 1299 days of patent term adjustment (USPTO delay)
Today
Lapsed Jun 6, 2025
2003 2027
Clock starts
Oct 24, 2003
No longer in force
Jun 6, 2025
Granted
Jun 6, 2017
Term would have run to
May 15, 2027
base term patent term adjustment after the term ends fee events Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,299
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
82
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to May 15, 2027: its 20-year base term plus 1299 days of term adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 24, 2003, when application PCT/IB2003/005527, the earliest non-provisional in its chain, was filed (this one was filed Mar 11, 2005); a parent in its chain could not be resolved (the next row)Oct 24, 2023High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+1299 days, USPTO patent term adjustment recordMay 15, 2027High confidence
Terminal disclaimer capDisclaimer on file (filed), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidlapsed Jun 6, 2025High confidence
Computed term endThe steps above, in orderJun 6, 2025Low confidence

Partial family

Application PCT/IB0300/005527PCT application
no patent term
no patent term
Application PCT/IB2003/005527PCT application
no patent term
no patent term
US 7,820,145In force
Aug 2028
Aug 2028
Application 10/911,367Abandoned
not computed
not computed
US 7,700,076In force
no later than Sep 2027
no later than Sep 2027
Application 11/041,921Abandoned
not computed
not computed
US 9,668,972this patent
Jun 2025
Jun 2025
Application 11/078,948Abandoned
not computed
not computed
8 of 82 applications in this family shown, earliest filings first. Partial: 5 of the 82 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 28, 2005
Reel 16426, frame 761
Tamarkin, Dov; Eini, Meir; Friedman, DoronFoamix Ltd.Assignment of Assignor's Interest
Jun 30, 2005
Reel 16741, frame 449
Tamarkin, Dov; Eini, Meir; Friedman, DoronFoamix Ltd.Assignment of Assignor's Interest
Jul 30, 2014
Reel 33445, frame 249
Foamix Ltd.Foamix Pharmaceuticals Ltd.Change of Name
Jul 30, 2019
Reel 49912, frame 45
Foamix Pharmaceuticals Ltd.Perceptive Credit Holdings II, LPPatent Security Agreement
Nov 4, 2020
Reel 54306, frame 387
Foamix Pharmaceuticals Ltd.Vyne Pharmaceuticals Ltd.Change of Name
Feb 4, 2021
Reel 55215, frame 298
Vyne Pharmaceuticals Ltd.Vyne Therapeutics Inc.Assignment of Assignor's Interest
Feb 17, 2021
Reel 55326, frame 9
Vyne Therapeutics Inc.Perceptive Credit Holdings II, LPPatent Security Agreement
Sep 20, 2021
Reel 57544, frame 138
Perceptive Credit Holdings II, LPVyne Pharmaceuticals Ltd. (F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Sep 20, 2021
Reel 57544, frame 708
Perceptive Credit Holdings II, LPVyne Therapeutics Inc. (F/K/A Menlo Therapeutics Inc. and Successor-in-Interest to Vyne Pharmaceuticals Ltd., F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited